Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/80003
Title: | Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor | Authors: | Li XX Zhang, SJ Chiu AP Lo LH Huang, J Rowlands, DK Wang, J Keng, VW |
Issue Date: | Sep-2018 | Source: | Cancer medicine, Sept. 2018, v. 7, no. 9, p. 4791-4800 | Abstract: | Malignant peripheral nerve sheath tumors (MPNSTs) are an aggressive form of soft tissue neoplasm with extremely poor prognosis and no effective medical options currently available. MPNSTs can occur either sporadically or in association with the neurofibromatosis type 1 (NF1) syndrome. Importantly, activation of RAS/RAF/MEK/ERK, PI3K/AKT/mTOR, and WNT/CTNNB1 signaling pathways has been reported in both NF1-related and late-stage sporadic MPNSTs. In this study, we found that DAW22, a natural sesquiterpene coumarin compound isolated from Ferula ferulaeoides (Steud.) Korov., could inhibit cell proliferation and colony formation in five established human MPNST cancer cell lines. Further molecular mechanism exploration indicated that DAW22 could target the main components in the MPNST tumorigenic pathways: namely suppress phosphorylation of AKT and ERK, and reduce levels of non-phospho (active) CTNNB1. Using the xenograft mouse model transplanted with human MPNST cancer cell line, daily treatment with DAW22 for 25 days was effective in reducing tumor growth. These results support DAW22 as an alternative therapeutic compound for MPNST treatment by affecting multiple signaling transduction pathways in its disease progression. | Keywords: | AKT Apoptosis DAW22 ERK MPNST |
Publisher: | John Wiley & Sons | Journal: | Cancer medicine | ISSN: | 2045-7634 | DOI: | 10.1002/cam4.1732 | Rights: | This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. © 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. The following publication Li, X. -., Zhang, S. -., Chiu, A. P., Lo, L. H., Huang, J., Rowlands, D. K., . . . Keng, V. W. (2018). Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor. Cancer Medicine, 7(9), 4791-4800 is available at https://dx.doi.org/10.1002/cam4.1732 |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Li_DAW22_Potential_Therapeutic.pdf | 1.04 MB | Adobe PDF | View/Open |
Page views
115
Last Week
0
0
Last month
Citations as of Apr 21, 2024
Downloads
93
Citations as of Apr 21, 2024
SCOPUSTM
Citations
12
Last Week
0
0
Last month
Citations as of Apr 26, 2024
WEB OF SCIENCETM
Citations
9
Last Week
0
0
Last month
Citations as of Apr 25, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.